Ludwig Hantson, CEO at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 6,488 shares at $95.85 ($622K) on 2018-12-31, disclosed to the SEC on 2019-01-03.
Open-market sale of $622k ALXN by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.85 | 3,244 | $311K | 50.0% |
| 2 | $95.85 | 3,244 | $311K | 50.0% |
| Total | $95.85 avg | 6,488 | $622K | 100% |
| Filing → |
| ALXN | BUY | 2017-06-19 | $1.2M | — | Filing → |
| BAX | SELL | 2014-07-11 | $1.9M | — | Filing → |
| BAX | SELL | 2013-01-29 | $710K | — | Filing → |